Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons · 2025
Minimally invasive percutaneous tarsometatarsal fusion with bone autograft, non-compression screws, and immediate postoperative weightbearing.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Marciano Gerard F, Confino Jamie, Vulcano Ettore
Аннотация
BACKGROUND: Percutaneous tarsometatarsal (TMT) fusion is a novel technique with sparse reported literature. This study aims to evaluate patient reported outcomes, fusion and complication rates following percutaneous TMT fusion.
METHODS: All patients who underwent percutaneous TMT fusion by a single surgeon with at least one year follow-up from February 2018 to July 2021 were retrospectively reviewed. Pre- and post-operative patient reported outcomes were assessed with Visual Analog Scale (VAS) and Foot Function Index (FFI). Fusion was assessed radiographically at each postoperative visit.
RESULTS: 38 patients with 86 TMT joints were included. Mean age was 60.8 years (range, 46-89 years). Mean follow up was 26.2 months (range, 17-39 months). Mean VAS scores improved from 7.5 to 0.2. Mean pre-operative FFI in pain, disability, activity restriction, and total score was 21.1, 16.5, 18.3 and 56.2, respectively. Mean post-operative FFI in pain, disability, activity restriction, and total score was 4.3, 4.7, 6.5 and 15.7, respectively. All pre- and post-operative differences in FFI and VAS were statistically significant (p < 0.0001). Fusion was achieved in 81/86 TMT (94.1 %).
CONCLUSION: Percutaneous TMT fusion achieves a high fusion rate and significantly improved patient reported outcomes in all domains.
LEVEL OF EVIDENCE: IV.
METHODS: All patients who underwent percutaneous TMT fusion by a single surgeon with at least one year follow-up from February 2018 to July 2021 were retrospectively reviewed. Pre- and post-operative patient reported outcomes were assessed with Visual Analog Scale (VAS) and Foot Function Index (FFI). Fusion was assessed radiographically at each postoperative visit.
RESULTS: 38 patients with 86 TMT joints were included. Mean age was 60.8 years (range, 46-89 years). Mean follow up was 26.2 months (range, 17-39 months). Mean VAS scores improved from 7.5 to 0.2. Mean pre-operative FFI in pain, disability, activity restriction, and total score was 21.1, 16.5, 18.3 and 56.2, respectively. Mean post-operative FFI in pain, disability, activity restriction, and total score was 4.3, 4.7, 6.5 and 15.7, respectively. All pre- and post-operative differences in FFI and VAS were statistically significant (p < 0.0001). Fusion was achieved in 81/86 TMT (94.1 %).
CONCLUSION: Percutaneous TMT fusion achieves a high fusion rate and significantly improved patient reported outcomes in all domains.
LEVEL OF EVIDENCE: IV.